After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

HORIZON-JU-GH-EDCTP3-2024-01-06-two-stage Call successful submission

A consortium composed by University of Sciences, Technologies and Techniques of Bamako (USTTB, Mali), Ministry of Health of Burkina Faso,  University of Bordeaux (France), and Fondazione Bruno Kessler (FBK, Italy)

Read More

R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and

Read More

Neglected Tropical Diseases affect 1 in 5 people in the world

Neglected Tropical Diseases affect 1 in 5 people worldwide. Affecting over 1.7 billion people, the Neglected Tropical Diseases impair physical and cognitive development, contribute to mother and child illness and

Read More